本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

26.14
+2.6311.19%
盤後26.250.1100+0.42%16:35 EDT
成交量:506.23萬
成交額:1.29億
市值:32.69億
市盈率:121.35
高:26.39
開:23.63
低:23.63
收:23.51
52周最高:31.77
52周最低:16.57
股本:1.25億
流通股本:1.11億
量比:2.18
換手率:4.55%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
淨資產收益率:15.86%
總資產收益率:5.09%
市淨率:14.82
市盈率(LYR):-206.05

資料載入中...

2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/18

重要事件披露

Form 8-K - Current report
2023/11/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/31

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/24

重要事件披露

Form 8-K - Current report
2023/10/19

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K - Current report
2023/09/16

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/09/16

SEC問詢函

Form CORRESP - Correspondence
2023/09/15

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/09/15

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/09/07

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities